We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Jazz Pharmaceuticals Inc. said the U.S. Food and Drug Administration has asked for more information on its anxiety drug Luvox CR. Silicon Valley/San Jose Business Journal
